Results 51 to 60 of about 185,181 (328)
British medical journal, 2017 Objective To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg compared with warfarin among patients with atrial fibrillation who had not previously taken an oral anticoagulant.
P. Nielsen +5 more
semanticscholar +1 more source
One Rare Warfarin Resistance Case and Possible Mechanism Exploration
Pharmacogenomics and Personalized Medicine, 2023 Li Zhao,1 Zhenguo Zhai,2 Pengmei Li1 1Pharmacy Department, China-Japan Friendship Hospital, Beijing, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, People’s Republic of ...
Zhao L, Zhai Z, Li P
doaj
Spontaneous abdominal hemorrhage due to warfarin treatment
CHRISMED Journal of Health and Research, 2016 Warfarin is an anticoagulant used in the prevention of thromboembolism. Common clinical indications for warfarin use are atrial fibrillation, artificial heart valves, deep venous thrombosis. Common side effect of warfarin is hemorrhage.
Mustafa Volkan Demir +3 more
doaj +1 more source
Risk factors of ischemic stroke and subsequent outcome in hemodialysis patients [PDF]
, 2015 Background and purpose: End stage renal disease (ESRD) requiring hemodialysis (HD) carries up to a 10-fold greater risk of stroke than normal renal function. Knowledge concerning risk factors and management strategies derived from the general population
Dawson, Jesse +9 more
core +1 more source
Scientific ReportsWarfarin remains the most prescribed oral anticoagulant of choice in atrial fibrillation (AF) patient in resource-limited settings. Despite evidence linking Time in Therapeutic Range (TTR) to patient outcomes, its use in clinical practice is not ...
Paisit Kosum +8 more
doaj +1 more source
Estimation of the warfarin dose with clinical and pharmacogenetic data.
New England Journal of Medicine, 2009 BACKGROUND Genetic variability among patients plays an important role in determining the dose of warfarin that should be used when oral anticoagulation is initiated, but practical methods of using genetic information have not been evaluated in a diverse ...
T. Klein +11 more
semanticscholar +1 more source
PERBANDINGAN DAYA BUNUH WARFARIN 0,105% DAN BRODIFACOUM 0,005% TERHADAP MENCIT (Mus Musculus) [PDF]
, 2005 Tikus adalah rodensia yang berperan sebagai tuan rumah perantara untuk beberapa jenis penyakit yang dikenal sebagai penyakit tular rodensia, selain dapat menimbulkan berbagai gangguan dan kerugian ekonomi.
LISTYADEWI , RATNA SARI LISTYADEWI
core
Three- versus four-factor prothrombin complex concentrate for the reversal of warfarin-induced bleeding [PDF]
, 2018 Objective: The objective of this study was to evaluate the effectiveness of 3-factor prothrombin complex concentrate (3F-PCC) compared to 4-factor PCC (4F-PCC) in warfarin-associated bleeding. Methods: This multicenter, retrospective, cohort study
Abraham, Prasad +6 more
core +1 more source
Advances on Albumin‐Based Carriers for Anticancer Drug Delivery
Advanced NanoBiomed Research, EarlyView.This study systematically classifies the drug delivery modes of albumin by examining the characteristics of its surface‐active groups and internal binding sites. It provides an in‐depth analysis of various drug delivery strategies and their corresponding targeting mechanisms.
Ruoli Zhou +4 more
wiley +1 more source
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2016 Background The introduction of non–vitamin K antagonist oral anticoagulants has been a major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in clinical trials may not translate to routine practice.
Xiaoxi Yao +6 more
semanticscholar +1 more source